These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 17000659)

  • 1. A new generation of mouse models of cancer for translational research.
    Abate-Shen C
    Clin Cancer Res; 2006 Sep; 12(18):5274-6. PubMed ID: 17000659
    [No Abstract]   [Full Text] [Related]  

  • 2. Practices and pitfalls of mouse cancer models in drug discovery.
    Kung AL
    Adv Cancer Res; 2007; 96():191-212. PubMed ID: 17161681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous and genetically engineered animal models; use in preclinical cancer drug development.
    Hansen K; Khanna C
    Eur J Cancer; 2004 Apr; 40(6):858-80. PubMed ID: 15120042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in molecular carcinogenesis: current and future use of mouse models to screen and validate molecularly targeted anticancer drugs.
    Frijhoff AF; Conti CJ; Senderowicz AM
    Mol Carcinog; 2004 Apr; 39(4):183-94. PubMed ID: 15057870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mighty mouse: genetically engineered mouse models in cancer drug development.
    Sharpless NE; Depinho RA
    Nat Rev Drug Discov; 2006 Sep; 5(9):741-54. PubMed ID: 16915232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using genetically engineered mouse models of cancer to aid drug development: an industry perspective.
    Singh M; Johnson L
    Clin Cancer Res; 2006 Sep; 12(18):5312-28. PubMed ID: 17000664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling therapy resistance in genetically engineered mouse cancer models.
    Rottenberg S; Jonkers J
    Drug Resist Updat; 2008; 11(1-2):51-60. PubMed ID: 18165147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chapter 6. Mouse models to investigate anti-cancer effects of VEGF inhibitors.
    Crawford Y; Ferrara N
    Methods Enzymol; 2008; 445():125-39. PubMed ID: 19022058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conditional mouse models of cancer.
    Vignjevic D; Fre S; Louvard D; Robine S
    Handb Exp Pharmacol; 2007; (178):263-87. PubMed ID: 17203659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging role of new transgenic mouse models in glioma research.
    Sonabend AM; Ulasov IV; Lesniak MS
    Expert Rev Anticancer Ther; 2007 Dec; 7(12 Suppl):S7-13. PubMed ID: 18076321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited role of cell kinetics in clinical cancer chemotherapy.
    Hall TC
    Natl Cancer Inst Monogr; 1971 Dec; 34():15-7. PubMed ID: 4946579
    [No Abstract]   [Full Text] [Related]  

  • 12. Humanized mice in translational biomedical research.
    Shultz LD; Ishikawa F; Greiner DL
    Nat Rev Immunol; 2007 Feb; 7(2):118-30. PubMed ID: 17259968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating drug efficacy and toxicology in three dimensions: using synthetic extracellular matrices in drug discovery.
    Prestwich GD
    Acc Chem Res; 2008 Jan; 41(1):139-48. PubMed ID: 17655274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of targeted mouse models for preclinical testing of novel cancer therapeutics.
    Olive KP; Tuveson DA
    Clin Cancer Res; 2006 Sep; 12(18):5277-87. PubMed ID: 17000660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic and translational research: from molecule, to mouse, to man.
    Adams V; Möbius-Winkler S; Schuler G
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S48-52. PubMed ID: 19675437
    [No Abstract]   [Full Text] [Related]  

  • 16. On the development of models in mice of advanced visceral metastatic disease for anti-cancer drug testing.
    Man S; Munoz R; Kerbel RS
    Cancer Metastasis Rev; 2007 Dec; 26(3-4):737-47. PubMed ID: 17846863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New derivatives of farnesylthiosalicylic acid (salirasib) for cancer treatment: farnesylthiosalicylamide inhibits tumor growth in nude mice models.
    Goldberg L; Haklai R; Bauer V; Heiss A; Kloog Y
    J Med Chem; 2009 Jan; 52(1):197-205. PubMed ID: 19072665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increasing attention.
    NicNiocaill B; Williams SD; Gölitz P
    ChemMedChem; 2008 Jan; 3(1):3-5. PubMed ID: 18172911
    [No Abstract]   [Full Text] [Related]  

  • 19. The origins of oncomice: a history of the first transgenic mice genetically engineered to develop cancer.
    Hanahan D; Wagner EF; Palmiter RD
    Genes Dev; 2007 Sep; 21(18):2258-70. PubMed ID: 17875663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Animal models of wound healing: utility in transgenic mice.
    Fang RC; Mustoe TA
    J Biomater Sci Polym Ed; 2008; 19(8):989-1005. PubMed ID: 18644226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.